Written question asked by Lord Morris of Manchester (Labour), in the House of Lords. It was answered by Baroness Taylor of Bolton (Labour) on Monday, 23 February 2009.

Gulf War: NAPS Tablets

Question: To ask Her Majesty's Government further to the Written Answer by Baroness Taylor of Bolton on 22 January (WA 221–22), whether they will ask theCommission on Human Medicine to review the decision not to include any restriction on co-administration in the instructions for the use of the nerve agent pre-treatment sets (NAPS) tablets, each containing pyridostigmine bromide, used for the troops deployed to the 1990–91 Gulf conflict in the light of the findings of the Congressionally-mandated United States Research Advisory Committee on Gulf War Veterans' Illnesses published on 17 November 2008; and whether they will arrange for a copy of the letter to be sent by Baroness Taylor of Bolton to be published in the Official Report.

Answer: As set out in the Written Answer of 22 January 2009 (WA 221-222), it is necessary to research our records on the issue prior to providing my noble friend with a substantive reply. We will arrange for the letter to be published in the Official Report, or deposited in the Library of the House as appropriate.

Secondary information

Type: Written question
Reference: 995; 708 c15-6WA
Session: 2008-09
Related items: Gulf War: NAPS Tablets
Thursday, 22 January 2009
Written questions
House of Lords
Subjects: Armed forces Chemical weapons Health hazards Iraq-Kuwait conflict Protection Preventive medicine Gulf War syndrome Pyridostigmine bromide US Research Advisory Committee on Gulf War Veterans' Illnesses Commission on Human Medicines
Link: View this Written question on www.publications.parliament.uk